Efficacy and safety of odanacatib in the treatment of postmenopausal women with osteoporosis: a meta-analysis

Abstract Background Osteoporosis, a systemic skeletal disease, seriously affects the quality of life in postmenopausal women. As one type of cathepsin K (CatK) inhibitor, odanacatib (ODN) is a fresh medication for osteoporosis. Considering the potential of ODN, we further examined the effect and saf...

Full description

Bibliographic Details
Published in:Journal of Orthopaedic Surgery and Research
Main Authors: Jiaxuan Li, Qi Qiu, Shide Jiang, Jianfeng Sun, Volotovski Pavel, Yusheng Li
Format: Article
Language:English
Published: BMC 2024-08-01
Subjects:
Odanacatib
Postmenopausal osteoporosis
Efficacy
Safety
Online Access:https://doi.org/10.1186/s13018-024-05008-z

Internet

https://doi.org/10.1186/s13018-024-05008-z

Similar Items